跳至主要内容
临床试验/CTRI/2020/08/027043
CTRI/2020/08/027043尚未招募1 期

A Phase 1 clinical trial of intravenous administration of mesenchymal stem cells derived from umbilical cord and placenta in patients with novel COVID-19 virus pneumonia.

eurogen Brain and Spine Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients admitted with RT-PCR confirmed COVID-19 illness.
  • Age: 18-65 years without any uncontrolled comorbidities like hypertension, diabetes, renal failure, etc
  • Written informed consent
  • Has any of the two
  • PaO2/ FiO2: 200-300
  • Respiratory Rate > 24/min and SaO2 <= 93% on room air

排除标准

  • Pregnant women
  • Breastfeeding women
  • Critically ill patients:
  • P/F ratio < 200 (ARDS )
  • Shock (Requiring Vasopressor to maintain a MAP >= 65mmHg or MAP below 65)
  • Patients with other severe co-morbidities like cancer, chronic renal, chronic liver failure and chronic cardiac failure. This will not include diabetes, hypertension, etc
  • Participating in any other clinical trial

研究者

发起方
eurogen Brain and Spine Institute

相似试验